发明名称 HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY
摘要 The present invention concerns methods and compositions for in vivo and in vitro targeting. A large number of targeting peptides directed towards human organs, tissues or cell types are disclosed. The peptides are of use for targeted delivery of therapeutic agents, including but not limited to gene therapy vectors. A novel class of gene therapy vectors is disclosed. Certain of the disclosed peptides have therapeutic use for inhibiting angiogenesis, inhibiting tumor growth, inducing apoptosis, inhibiting pregnancy or inducin g weight loss. Methods of identifying novel targeting peptides in humans, as well as identifying endogenous receptor-ligand pairs are disclosed. Methods of identifying novel infectious agents that are causal for human disease states are also disclosed. A novel mechanism for inducing apoptosis is further disclosed.
申请公布号 CA2421271(A1) 申请公布日期 2002.03.14
申请号 CA20012421271 申请日期 2001.09.07
申请人 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 发明人 ARAP, WADIH;PASQUALINI, RENATA
分类号 C12N15/09;A61K31/225;A61K31/23;A61K31/56;A61K31/683;A61K31/685;A61K31/688;A61K31/713;A61K35/12;A61K35/76;A61K38/00;A61K39/00;A61K39/02;A61K39/12;A61K39/395;A61K45/00;A61K47/42;A61K47/48;A61K48/00;A61K49/00;A61P3/10;A61P7/00;A61P9/00;A61P9/10;A61P13/02;A61P19/02;A61P25/28;A61P29/00;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P37/02;A61P37/04;A61P43/00;C07K1/04;C07K5/08;C07K5/10;C07K7/04;C07K7/06;C07K7/08;C07K14/00;C07K14/005;C07K14/47;C07K14/52;C07K16/08;C07K16/18;C07K19/00;C12N7/02;C12N15/10;C12N15/861;C12N15/864;C12Q1/02;C12Q1/70;G01N33/50;G01N33/53;G01N33/566;(IPC1-7):C12N15/03;C07K7/00;C07K17/02;A61K38/03;A61K38/04;C12N15/07;A61K38/08;A61K38/17;C12N15/73;C12N15/74;C12N15/75 主分类号 C12N15/09
代理机构 代理人
主权项
地址